These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 19998498)

  • 41. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
    Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
    Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional plasticity of Th17 cells: implications in gastrointestinal tract function.
    Garrido-Mesa N; Algieri F; Rodríguez Nogales A; Gálvez J
    Int Rev Immunol; 2013; 32(5-6):493-510. PubMed ID: 24040751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Th17 cells and mucosal host defense.
    Aujla SJ; Dubin PJ; Kolls JK
    Semin Immunol; 2007 Dec; 19(6):377-82. PubMed ID: 18054248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease.
    Iboshi Y; Nakamura K; Ihara E; Iwasa T; Akiho H; Harada N; Nakamuta M; Takayanagi R
    Inflamm Bowel Dis; 2014 Jun; 20(6):967-77. PubMed ID: 24739631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses?
    Brandtzaeg P
    Acta Odontol Scand; 2001 Aug; 59(4):235-43. PubMed ID: 11570527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
    Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
    World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm.
    Liu JZ; Pezeshki M; Raffatellu M
    Cytokine; 2009; 48(1-2):156-60. PubMed ID: 19665391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis.
    Sheibanie AF; Yen JH; Khayrullina T; Emig F; Zhang M; Tuma R; Ganea D
    J Immunol; 2007 Jun; 178(12):8138-47. PubMed ID: 17548652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
    Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comprehensive immunobiology review of IBD: With a specific glance to Th22 lymphocytes development, biology, function, and role in IBD.
    Lv J; Ibrahim YS; Yumashev A; Hjazi A; Faraz A; Alnajar MJ; Qasim MT; Ghildiyal P; Hussein Zwamel A; Fakri Mustafa Y
    Int Immunopharmacol; 2024 Aug; 137():112486. PubMed ID: 38901239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Th17 plasticity and its relevance to inflammatory bowel disease.
    Ueno A; Jeffery L; Kobayashi T; Hibi T; Ghosh S; Jijon H
    J Autoimmun; 2018 Feb; 87():38-49. PubMed ID: 29290521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of cytokines in inflammatory bowel disease.
    Sanchez-Munoz F; Dominguez-Lopez A; Yamamoto-Furusho JK
    World J Gastroenterol; 2008 Jul; 14(27):4280-8. PubMed ID: 18666314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the IL23/IL17 Pathway in Crohn's Disease.
    Schmitt H; Neurath MF; Atreya R
    Front Immunol; 2021; 12():622934. PubMed ID: 33859636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Innate Lymphoid Cells in Inflammatory Bowel Disease.
    Li J; Glover SC
    Arch Immunol Ther Exp (Warsz); 2018 Dec; 66(6):415-421. PubMed ID: 30155762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Th17 cytokines and mucosal immunity.
    Dubin PJ; Kolls JK
    Immunol Rev; 2008 Dec; 226():160-71. PubMed ID: 19161423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.
    Imam T; Park S; Kaplan MH; Olson MR
    Front Immunol; 2018; 9():1212. PubMed ID: 29910812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
    Abraham C; Cho JH
    Annu Rev Med; 2009; 60():97-110. PubMed ID: 18976050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of Th17 Cells in the Pathogenesis of Human IBD.
    Gálvez J
    ISRN Inflamm; 2014; 2014():928461. PubMed ID: 25101191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.